OpenEvidence takes clinical AI across a major New York health system
OpenEvidence is expanding across NewYork-Presbyterian, Columbia and Weill Cornell in a large enterprise-scale clinical AI deployment.
Clinical AI is increasingly competing on workflow distribution and institutional trust, not only model capability.
What happened
OpenEvidence announced an enterprise-scale collaboration with NewYork-Presbyterian, Columbia University Vagelos College of Physicians and Surgeons, and Weill Cornell Medicine.
The clinical AI system is being made available across hospitals and care sites throughout Greater New York.
Clinical staff can ask medical questions conversationally and receive answers grounded in research and guidelines.
Why it matters
This is materially different from a small pilot.
Deployment across a major academic health system and two leading medical schools gives the product access to real clinical workflows and a broad professional user base.
That makes adoption, trust and institutional integration as important as raw AI capability.
The bigger picture
Clinical AI is moving from experimentation toward embedded infrastructure.
The strongest companies may be those that win distribution inside trusted health systems rather than simply release the most impressive standalone model. OpenEvidence’s expansion reflects that shift.